The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...
Federal Trade Commission Chair Andrew Ferguson has refused to commit to resisting President Donald Trump if he ordered the ...
The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...
Federal Trade Commission (FTC) chair Andrew Ferguson on Wednesday defended President Trump’s decision to fire the agency’s ...
Whoever buys 23andMe should be required to keep customer data private, according to the US Federal Trade Commission. The FTC ...
A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings. The former chair is not pleased.
Explore more
The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers. | The agency ...
The Supreme Court unanimously held in a 1935 case, Humphrey's Executor v. United States, that "Congress intended to restrict ...
As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of ...
A powerful member of the Federal Trade Commission has been working her high-profile post remotely – despite President Trump’s ...
President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members ...
The Federal Trade Commission has paused an enforcement action alleging pharmacy benefit managers used illegal rebate programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results